Tristel plc (TSTL) is a leading medical instruments & supplies business based in the UK. It opened the day at 530p after a previous close of 520p. During the day the price has varied from a low of 517p to a high of 542p. The latest price was 535p (25 minute delay). Tristel is listed on the London Stock Exchange (LSE) and employs 160 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Tristel's share price has had significant positive movement.
Its last market close was 498p, which is 20.68% up on its pre-crash value of 395p and 83.76% up on the lowest point reached during the March crash when the shares fell as low as 271p.
If you had bought £1,000 worth of Tristel shares at the start of February 2020, those shares would have been worth £1,129.09 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,260.74.
|52-week range||267.4728p - 560p|
|50-day moving average||513.2647p|
|200-day moving average||469.3838p|
|Wall St. target price||300p|
|Dividend yield||0.06p (1.16%)|
|Earnings per share (TTM)||10.9p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|3 months (2020-10-19)||7.00%|
|6 months (2020-07-17)||17.58%|
Valuing Tristel stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tristel's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tristel's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 49x. In other words, Tristel shares trade at around 49x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Tristel's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £8.2 million.
The EBITDA is a measure of a Tristel's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£31.7 million|
|Operating margin TTM||21.88%|
|Gross profit TTM||£25.2 million|
|Return on assets TTM||12.52%|
|Return on equity TTM||19.68%|
|Market capitalisation||£248.9 million|
TTM: trailing 12 months
Dividend payout ratio: 5618.18% of net profits
Recently Tristel has paid out, on average, around 5618.18% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Tristel shareholders could enjoy a 1.16% return on their shares, in the form of dividend payments. In Tristel's case, that would currently equate to about 0.06p per share.
Tristel's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 19 November 2020 (the "ex-dividend date").
Over the last 12 months, Tristel's shares have ranged in value from as little as 267.4728p up to 560p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Tristel's is 0.599. This would suggest that Tristel's shares are less volatile than average (for this exchange).
Tristel plc develops, manufactures, and supplies infection and contamination control, and hygiene products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products under the Tristel brand; surface cleaning and disinfection products used in areas, such as hospitals, rescue vehicles, care homes, hospices, dentists, and GP surgeries under the Cache brand; contamination control products for pharmaceutical and personal care industries under the Crystel brand; and animal health infection prevention and control products under the Anistel brand. Tristel plc was founded in 1993 and is based in Snailwell, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.